177 related articles for article (PubMed ID: 7536494)
1. Markedly high population of affected reticulocytes negative for decay-accelerating factor and CD59 in paroxysmal nocturnal hemoglobinuria.
Iwamoto N; Kawaguchi T; Nagakura S; Hidaka M; Horikawa K; Kagimoto T; Takatsuki K; Nakakuma H
Blood; 1995 Apr; 85(8):2228-32. PubMed ID: 7536494
[TBL] [Abstract][Full Text] [Related]
2. Longer in vivo survival of CD59- and decay-accelerating factor-almost normal positive and partly positive erythrocytes in paroxysmal nocturnal hemoglobinuria as compared with negative erythrocytes: a demonstration by differential centrifugation and flow cytometry.
Fujioka S; Yamada T
Blood; 1992 Apr; 79(7):1842-5. PubMed ID: 1373090
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis of paroxysmal nocturnal haemoglobinuria by phenotypic analysis of erythrocytes using two-colour flow cytometry with monoclonal antibodies to DAF and CD59/MACIF.
Shichishima T; Terasawa T; Saitoh Y; Hashimoto C; Ohto H; Maruyama Y
Br J Haematol; 1993 Oct; 85(2):378-86. PubMed ID: 7506570
[TBL] [Abstract][Full Text] [Related]
4. Expression of decay-accelerating factor and CD59 in lymphocyte subsets of healthy individuals and paroxysmal nocturnal hemoglobinuria patients.
Nagakura S; Nakakuma H; Horikawa K; Hidaka M; Kagimoto T; Kawakita M; Tomita M; Takatsuki K
Am J Hematol; 1993 May; 43(1):14-8. PubMed ID: 7686331
[TBL] [Abstract][Full Text] [Related]
5. Investigation of the survival of paroxysmal nocturnal hemoglobinuria red cells through the immunophenotyping of reticulocytes.
Navenot JM; Muller JY; Blanchard D
Transfusion; 1998 Apr; 38(4):337-42. PubMed ID: 9595015
[TBL] [Abstract][Full Text] [Related]
6. Discordant and heterogeneous expression of GPI-anchored membrane proteins on leukemic cells in a patient with paroxysmal nocturnal hemoglobinuria.
Shichishima T; Terasawa T; Hashimoto C; Ohto H; Takahashi M; Shibata A; Maruyama Y
Blood; 1993 Apr; 81(7):1855-62. PubMed ID: 7681703
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic analysis of affected peripheral erythroid for CD59 in paroxysmal nocturnal hemoglobinuria.
Cui W; Lin Q; Zhang Z
Chin Med J (Engl); 2002 Feb; 115(2):206-8. PubMed ID: 11940332
[TBL] [Abstract][Full Text] [Related]
8. Quantitation of CD55 and CD59 expression on reticulocytes and mature erythrocytes in paroxysmal nocturnal hemoglobinuria, aplastic anemia, and healthy control subjects.
Kim Y; Lim J; Kim M; Kim Y; Lee JW; Han K
Ann Clin Lab Sci; 2010; 40(3):226-32. PubMed ID: 20689133
[TBL] [Abstract][Full Text] [Related]
9. Reticulocyte-gated flow cytometric analysis of red blood cells in paroxysmal nocturnal hemoglobinuria.
Sato S; Hasegawa Y; Nagasawa T; Ninomiya H
Lab Hematol; 2006; 12(2):82-5. PubMed ID: 16751135
[TBL] [Abstract][Full Text] [Related]
10. Heterogenous expression of decay accelerating factor and CD59/membrane attack complex inhibition factor on paroxysmal nocturnal haemoglobinuria (PNH) erythrocytes.
Shichishima T; Terasawa T; Hashimoto C; Ohto H; Uchida T; Maruyama Y
Br J Haematol; 1991 Aug; 78(4):545-50. PubMed ID: 1716957
[TBL] [Abstract][Full Text] [Related]
11. A simplified assay for the specific diagnosis of paroxysmal nocturnal hemoglobinuria: detection of DAF(CD55)- and HRF20(CD59)- erythrocytes in microtyping cards.
Nilsson B; Hagström U; Englund A; Säfwenberg J
Vox Sang; 1993; 64(1):43-6. PubMed ID: 7680511
[TBL] [Abstract][Full Text] [Related]
12. Immunophenotypic discrepancies between granulocytic and erythroid lineages in peripheral blood of patients with paroxysmal nocturnal haemoglobinuria.
Pakdeesuwan K; Wanachiwanawin W; Siripanyaphinyo U; Pattanapanyasat K; Wilairat P; Issaragrisil S
Eur J Haematol; 2000 Jul; 65(1):8-16. PubMed ID: 10914934
[TBL] [Abstract][Full Text] [Related]
13. Two distinct patterns of glycosylphosphatidylinositol (GPI) linked protein deficiency in the red cells of patients with paroxysmal nocturnal haemoglobinuria.
Hillmen P; Hows JM; Luzzatto L
Br J Haematol; 1992 Mar; 80(3):399-405. PubMed ID: 1374629
[TBL] [Abstract][Full Text] [Related]
14. The use of monoclonal antibodies and flow cytometry in the diagnosis of paroxysmal nocturnal hemoglobinuria.
Hall SE; Rosse WF
Blood; 1996 Jun; 87(12):5332-40. PubMed ID: 8652849
[TBL] [Abstract][Full Text] [Related]
15. Clinical paroxysmal nocturnal hemoglobinuria is the result of expansion of glycosyl-phosphatidyl-inositol-anchored protein-deficient clone in the condition of deficient hematopoiesis.
Pakdeesuwan K; Muangsup W; Pratya YU; Issaragrisil S; Wanachiwanawin W
Int J Hematol; 2001 Jan; 73(1):64-70. PubMed ID: 11372757
[TBL] [Abstract][Full Text] [Related]
16. [Rapid diagnosis of paroxysmal nocturnal hemoglobinuria by gel test agglutination].
Navenot JM; Bernard D; Petit-Frioux Y; Loirat MJ; Guimbretière J; Muller JY; Blanchard D
Rev Fr Transfus Hemobiol; 1993 Apr; 36(2):135-47. PubMed ID: 7684909
[TBL] [Abstract][Full Text] [Related]
17. Persistence of affected T lymphocytes in long-term clinical remission in paroxysmal nocturnal hemoglobinuria.
Nakakuma H; Nagakura S; Kawaguchi T; Iwamoto N; Hidaka M; Horikawa K; Kagimoto T; Tsuruzaki R; Takatsuki K
Blood; 1994 Dec; 84(11):3925-8. PubMed ID: 7524752
[TBL] [Abstract][Full Text] [Related]
18. Shortened lifespan of paroxysmal nocturnal haemoglobinuria-affected RBC estimated from differences in ratios of CD59-negative populations between reticulocytes and whole RBC.
Ninomiya H; Sato S; Hasegawa Y; Nagasawa T
Int J Lab Hematol; 2008 Feb; 30(1):41-5. PubMed ID: 18190466
[TBL] [Abstract][Full Text] [Related]
19. Flow cytometric analysis of glycosylphosphatidyl-inositol-anchored proteins to assess paroxysmal nocturnal hemoglobinuria clone size.
Piedras J; López-Karpovitch X
Cytometry; 2000 Aug; 42(4):234-8. PubMed ID: 10934342
[TBL] [Abstract][Full Text] [Related]
20. Immunophenotypic analysis of reticulocytes in paroxysmal nocturnal hemoglobinuria.
Ware RE; Rosse WF; Hall SE
Blood; 1995 Aug; 86(4):1586-9. PubMed ID: 7543308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
